-+ 0.00%
-+ 0.00%
-+ 0.00%

MustGrow Q2 2026 profit lifted by CAD 1.36 million technology license revenue, TerraSante sales constrained by manufacturing delays

PUBT·08/27/2026 21:18:48
Listen to the news
MustGrow Q2 2026 profit lifted by CAD 1.36 million technology license revenue, TerraSante sales constrained by manufacturing delays
  • MustGrow posted income of CAD 284,695 for the three months ended June 30, 2026, swinging from a CAD 1.09 million loss.
  • Six-month loss narrowed to CAD 1.04 million from CAD 2.73 million, driven by CAD 1.36 million in technology license revenue.
  • TerraSante sales fell to CAD 74,789 in the quarter from CAD 312,833, citing contract manufacturers missing expected deliveries.
  • NexusBioAg results shifted to discontinued operations; six-month revenue was CAD 2.5 million with a CAD 579,635 loss.
  • Cash used in operations was CAD 1.66 million for the six months; working capital was CAD 5.19 million, including CAD 4.37 million cash.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. MustGrow Biologics Corp. published the original content used to generate this news brief on August 27, 2026, and is solely responsible for the information contained therein.